Metformin in the Diastolic Dysfunction of Metabolic Syndrome: MET-DIME Trial
Latest Information Update: 07 Nov 2021
Price :
$35 *
At a glance
- Drugs Metformin (Primary)
- Indications Diastolic heart failure; Left ventricular dysfunction; Metabolic syndrome
- Focus Therapeutic Use
- Acronyms MET-DIME
- 01 Jun 2021 Primary endpoint (Change in mean early diastolic mitral annular velocity (cm/s) (In the per-protocol analysis)) has been met.
- 01 Jun 2021 Primary endpoint (Change in mean early diastolic mitral annular velocity (cm/s) (in mITT analysis)) has not been met.
- 01 Jun 2021 Results published in the Endocrine